Heparinized Saline Should NOT Be Used During Dialysis for Patients with Active UGIB
Avoid systemic heparin anticoagulation during hemodialysis in patients with active upper gastrointestinal bleeding; use heparin-free dialysis with saline flushes instead. 1, 2
Rationale for Avoiding Heparin
The FDA labeling for heparin explicitly contraindicates its use in patients with "an uncontrolled active bleeding state" 2. This directly applies to patients with active UGIB undergoing dialysis, as systemic heparinization significantly increases bleeding risk and mortality in this population.
- Active bleeding is a contraindication to heparin use, with the FDA stating heparin should be avoided "except when the benefits outweigh the potential risks" in major bleeding scenarios 2
- Fatal hemorrhages have been documented with heparin use, including gastrointestinal hemorrhage, adrenal hemorrhage, and retroperitoneal bleeding 2
- Increased bleeding risk in elderly patients (>60 years), who comprise the majority of dialysis patients with UGIB 2
Recommended Dialysis Anticoagulation Strategy
Use heparin-free hemodialysis with saline flushes as the primary approach for patients with active UGIB 3, 4, 5.
Specific Protocol:
- Perform dialysis without any systemic heparin during the acute bleeding phase 3, 4, 5
- Implement regular saline flushes of the extracorporeal circuit (typically every 15-30 minutes) to maintain circuit patency 3, 5
- Consider heparin-bound membranes (such as Hemophan) as an alternative to reduce thrombosis risk without systemic anticoagulation 5
- Monitor circuit pressures closely to detect early clotting and intervene promptly 3, 5
Timing for Resuming Heparin
If heparin must eventually be resumed for dialysis circuit patency:
- Wait at least 3 days after the bleeding episode before considering any heparin use 1, 4
- Ensure hemostasis is achieved through endoscopic therapy and clinical stabilization before reintroducing anticoagulation 1, 6
- Use minimal heparinization (reduced doses) when restarting, though evidence shows many patients receive unchanged doses in practice 7
- For high thrombotic risk patients requiring bridging, use unfractionated heparin rather than LMWH due to its shorter half-life (1-2 hours) allowing rapid reversal if rebleeding occurs 1
Alternative Anticoagulation Options
If heparin-free dialysis proves technically difficult:
- Regional citrate anticoagulation can be considered as it provides circuit anticoagulation without systemic effects 8, 4, 5
- Prostacyclin anticoagulation is another regional option, though less commonly used 4, 5
- Minimal heparinization protocols (very low doses) only if absolutely necessary and bleeding has completely stopped 4, 5
Critical Caveats
- Patients with active UGIB are at highest risk for rebleeding when exposed to any anticoagulation 1, 9, 1
- The risk of rebleeding is greatest within the first 72 hours after the initial bleeding episode 1, 6
- Dialysis circuit clotting is an acceptable risk compared to potentially fatal rebleeding in this population 3, 4, 5
- Recent observational data suggests many dialysis units inappropriately continue heparin immediately after UGIB, highlighting a system-based practice gap that needs correction 7